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1. Introduction 
Genomic variability provides the basis for adaptation and evolution and constitutes a 
fascinating aspect of the metabolically and phylogenetically diverse microbial world. 
Variability in bacteria has been extensively studied both because it enables inferring 
evolutionary relationships and because it plays an important role in host-pathogen 
interactions. Microbiologists, who have long struggled with species classification, have 
gained a more recent appreciation of the level of genetic diversity in microorganisms that 
has led to new awareness of what may constitute a bacterial “species” (Doolittle & 
Zhaxybayeva, 2009). In the clinical setting, genomic variability can represent a significant 
barrier to treatment. Many pathogens can acquire mutations or foreign genetic material 
through horizontal gene transfer (HGT) in response to the selective pressure imposed by the 
host immune system and by chemotherapy (Hawkey & Jones, 2009, Sampson, 2011), 
resulting in strains that are difficult to eradicate in hospitals as well as during long-term 
infection. Understanding the extent of genomic variability and its effects on disease in the 
case of pathogens that display genetic homogeneity and low variability, as is the case for the 
causative agent of tuberculosis, Mycobacterium tuberculosis, is particularly fascinating. The 
success of M. tuberculosis is intimately tied to the infectious process and its interaction with 
the human host, which is believed to have resulted from a long process of co-evolution 
(Donoghue, 2009, Gutierrez et al., 2005). As a result, M. tuberculosis is capable of subverting 
the immune response and persisting as a latent form within an individual and for millennia 
within the human population. 
Despite the availability of chemotherapy and the continued efforts to control the disease, 
tuberculosis continues to be one of the top ten causes of morbidity and mortality worldwide, 
with approximately 9 million cases per year, according to the World Health Organization 
(Lawn & Zumla, 2011). In spite of the growing interest and continued efforts, there are still 
significant gaps in our knowledge regarding both the pathogen and its interaction with the 
host that hamper control strategies. The appearance and spread of multi-drug (MDR) as 
well as extensively drug resistant (XDR) strains of M. tuberculosis represent a growing threat 
worldwide and underscore the importance of effective diagnosis and treatment. Given the 
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burden to public health and the complexity of the disease, an effective control of 
tuberculosis must involve diverse approaches and will require a better understanding of the 
host as well as of the environmental and bacterial factors that govern disease outcome.  
M. tuberculosis belongs to the Mycobacterium tuberculosis Complex (MTBC), a group of slow-
growing mycobacteria that are closely related at the DNA level and share identical 16S 
rRNA gene sequences but that differ in terms of phenotypes and host preference (Brosch et 
al., 2001, Sreevatsan et al., 1997). The MTBC includes the human-adapted strains M. 
tuberculosis, Mycobacterium africanum and Mycobacterium canneti, being M. cannetti the most 
divergent within the MTBC complex (Gutierrez et al., 2005). The MTBC also includes 
animal-adapted strains. M. bovis has a wider host range and is the main cause of 
tuberculosis in other animal species. M. microti is a pathogen of rodents, M. pinnipedii causes 
disease in sea lions and seals, M. caprae is a pathogen of goats and, recently, “M. mungi” was 
isolated from mongoose (Alexander et al., 2010, Mostowy & Behr, 2005). The high similarity 
at the DNA level suggests that this group could have resulted from a bottleneck event that 
led to the expansion of a successful clone that then gave rise to different host-adapted 
ecotypes of the same species (Smith et al., 2006). 
Understanding the differences that underlie the biology and evolution of the MTBC has 
been the focus of considerable work (Smith et al., 2009, Comas & Gagneux, 2009). Members 
of the MTBC have a highly clonal population structure where recent events of HGT are 
essentially absent (Supply et al., 2003, Gutierrez et al., 2005). This contrasts with many other 
microorganisms where horizontally acquired genetic material can play important roles in 
acquisition of novel virulence determinants and properties such as antibiotic resistance and 
the capacity to exploit different environmental niches. Recent surveys using MTBC strains 
that are more representative of global isolates, as well as advances in genome sequence 
analysis, have indicated, however, that there is more variation than previously anticipated 
and that this variation can be used to both distinguish isolates as well as to trace 
phylogenetic lineages (Hershberg et al., 2008). 
A greater knowledge of the diversity present in M. tuberculosis and MTBC strains can also 
lead to deeper understanding of the biological consequences associated with strain 
variability. The variation in circulating M. tuberculosis isolates has been critical for 
identification of strains, outbreaks and changes within the population. It has also in some 
cases been associated with phenotypic properties that are relevant in terms of the disease, 
such as transmission potential, immunological response and manifestation of the disease 
(Nicol & Wilkinson, 2008). However, the link between genotypic and phenotypic properties 
is not necessarily evident given the complexity of the host-pathogen interaction and the 
effect of environmental factors. In this context, a deeper understanding of the population 
structure and dynamics of new clonal lineages, with mutations that contribute to a 
particular lineage’s success, can provide great insight regarding the appearance and spread 
of strain variants relevant to public health and to the control, treatment and eradication of 
tuberculosis. 
This chapter will provide an overview of recent studies regarding genetic variability in  
M. tuberculosis. This will include a brief description of the importance of variability for the 
study of the evolution of the MTBC. Also, we will address the mechanisms of genomic 
variation in a pathogen characterized by genetic homogeneity and inappreciable HGT by 
www.intechopen.com
 
Genomic Variability of Mycobacterium tuberculosis 
 
39 
illustrating how genomic variability can emerge as a consequence of mutations that result in 
Single Nucleotide Polymorphisms (SNPs) and Large Sequence Polymorphisms (LSPs), 
namely insertions and deletions. We will then discuss the importance of variability in 
disease outcome. 
2. Genetic diversity and phylogeny of M. tuberculosis 
The availability of the complete M. tuberculosis genome sequence (Cole et al., 1998) opened 
new ways to conduct studies and to understand the evolution of the closely related MTBC 
strains. By using Bacterial Artificial Chromosomes (BAC) libraries it was shown that seven 
loci were deleted in M. bovis with respect to M. tuberculosis, reinforcing previous studies 
indicating that these strains probably originated from a common ancestor (Gordon et al., 
1999, Sreevatsan et al., 1997). This was more fully appreciated by comparative genomics 
studies (Brosch et al., 2002) that also divided the M. tuberculosis strains into “ancient” and 
“modern” based on a deletion known as TbD1 in the modern strains. Several molecular 
markers have been developed to type strains and infer phylogenetic relationships. Some of 
these are considered more useful for epidemiological studies, such as transmission, re-
infection and/or reactivation, while others are considered more robust phylogenetic 
markers that can help to decipher the evolution of M. tuberculosis. The methods used for  
epidemiology include restriction fragment length polymorphism (RFLP) of IS6110 sites (van 
Embden et al., 1993, van Soolingen et al., 1993), spoligotyping to identify unique spacers 
within the Clustered Regulatory Short Palindromic Repeats (CRISPR) or Direct Repeat (DR) 
region (van Embden et al., 2000, Brudey et al., 2006, Kamerbeek et al., 1997), and the 
identification of Variable Number of Tandem Repeats-Mycobacterial Interspersed Repetitive 
Units (MIRUs-VNTR) that are strain-specific repeats of short DNA sequences at different 
positions of the chromosome (Supply et al., 2003). Molecular markers that provide more 
robust phylogenetic information and have helped to shape the evolutionary scenario of  
M. tuberculosis include LSP, SNPs and Multilocus Sequence Analysis (MLSA) (Filliol et al., 
2006, Gagneux et al., 2006, Gutacker et al., 2006, Comas et al., 2009) (Figure 1). Although it 
has been argued that the use of RFLPs, spoligotyping and VNTR markers is highly prone to 
convergent evolution and thus to homoplasies (i.e., the same spoligotyping can be observed 
in strains belonging to different lineages), recent studies show that, at least for the main 
lineages, this does not seem to be the case (Kato-Maeda et al., 2011). However, more studies 
are required to clarify this issue. 
Based on our current view of its evolutionary history, M. tuberculosis can be divided into six 
phylogeographical lineages, which have been adapted to their local human populations 
(Figure 1). The use of different molecular makers, such as spoligotyping, LSPs and SNPs, 
can also classify the global population of MTB into comparable groups. For instance, 
Lineage 1 (Indo-Oceanic lineage) corresponds to the East African-Indian (EAI) family; 
Lineage 2 (East Asian Lineage) corresponds to the Beijing family; Lineage 3 or East African-
Indian corresponds to the Central Asia (CAS) family; Lineage 4 is the Euro American 
Lineage that includes the Haarlem, LAM, X, T, S and Tuscany families; Lineage 5 (West 
African Lineage 1) and Lineage 6 (West African Lineage 2) correspond to AFRI 2 and AFRI 
1, respectively, by spoligotyping (Sola et al., 2001, Brudey et al., 2006). Based on the evidence 
accumulated from these studies, it has been suggested that M. tuberculosis evolved as a 
human pathogen in Africa, which is also the continent where all main M. tuberculosis 
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lineages have been isolated (Hershberg et al., 2008). Moreover, the “ancient” lineages 
described by Brosh (2002) are present in West Africa and the spread of the “modern” 
lineages are associated with the human migration out of the African continent (Wirth et al., 
2008, Hershberg et al., 2008).  
Phylogenetic studies have also shown that clinical strains of M. tuberculosis are more 
genetically variable than originally expected (Hirsh et al., 2004, Gagneux et al., 2006, 
Hershberg et al., 2008). Moreover, genetic variability can be translated into phenotypic 
differences, such as transmission capacity, virulence and pathogenicity that can have 
epidemiological consequences and affect the outcome of the disease. Although there are few 
studies showing a clear association between lineage and transmission capacity it is now 
clear that Lineage 2 (Beijing family) M. tuberculosis has spread globally more than any other 
lineage (Parwati et al., 2010). The use of spoligotyping to type paraffin-embedded strains 
obtained from tuberculosis patients in different time periods has also shown an increase of 
this genotype over time in Africa. Its isolation from children, which is a measure of recent 
transmission, increased from 13% in 2000 to 33% in 2003 in South Africa (Cowley et al., 
2008). The capacity of the Beijing genotype to spread more than other lineages is not 
completely understood but it has been suggested that factors contributing to its expansion 
could involve the selective pressure imposed by BCG vaccination and drug treatment 
(Parwati et al., 2010). 
 
Fig. 1. Schematic representation of the phylogeography of M. tuberculosis. squares indicate 
the 6 main Lineages and circles are representative of the spoligotype families 
The successful transmission of particular strains is not limited to the Beijing genotype. In a 
recent study, where guinea pigs were exposed to air from a HIV-tuberculosis ward, one 
non-Beijing strain was shown to be responsible for most of the secondary infections 
observed (Escombe et al., 2008). In addition to transmission capacity, it is also currently 
accepted that genetically different M. tuberculosis strains produce markedly different 
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immuno-pathological events and affect disease manifestation. For example, in a study 
conducted in Vietnamese patients, a clear association between the Euro American Lineages 
of M. tuberculosis and pulmonary rather than meningeal tuberculosis was observed, 
suggesting these strains are less capable of extra-pulmonary dissemination than other 
strains in the study population (Caws et al., 2008). In a study using a cohort of patients and 
household contacts in Gambia, both M. africanum and M. tuberculosis were equally 
transmitted to the household contacts but M. tuberculosis Beijing strains were most likely to 
progress to disease (de Jong et al., 2008). Another source of evidence came from a recent 
study associating Lineages 1, 5 and 6, with a higher pro-inflammatory cytokine response 
when compared with the modern Lineages 2, 3 and 4 (Portevin et al., 2011). 
3. SNPs in M. tuberculosis 
Genetic diversity within bacterial species is usually generated by mutations and by the 
exchange of genetic material. The process of HGT is thought to be an important driver of 
bacterial evolution in both pathogenic and non-pathogenic bacteria (Becq et al., 2007). 
Horizontally transferred genes can be acquired in clusters known as genomic islands or 
pathogenicity islands that can be identified by characteristics that distinguish them from the 
host genome, such as GC content, flanking nucleotide repeats and insertion elements. In the 
case of M. tuberculosis, there is evidence of ancient gene transfer events that could have 
taken place in a progenitor tubercle bacilli pool before the clonal expansion that gave rise to 
the MTBC (Gutierrez et al., 2005). One of these events involved the Rv0986-8 virulence 
operon (Rosas-Magallanes et al., 2006) that could have originated from genetic exchange 
between an environmental bacillus ancestor and other bacterial species (Nicol & Wilkinson, 
2008). In the absence of recent events of HGT, modern M. tuberculosis lineages evolve 
essentially by mutations that alter its genome, resulting in SNPs and LSPs, such as deletions 
and insertions, the latter mainly mediated by transposition of the IS6110 insertion element.  
Although allelic variation in MTBC organisms is quite restricted when compared with other 
pathogenic bacteria (Sreevatsan et al., 1997), there is a growing recognition that there is 
substantial genetic diversity among isolates. At the level of SNPs changes can be either 
synonymous (sSNP) or non-synonymous (nsSNP) and this diversity has been undeniably 
useful for typing and defining evolutionary relationships among strains. SNPs provide 
many advantages for the analysis of phylogenetic relationships among microorganisms, 
especially among closely related clonal organisms such as the MTBC. Initial descriptions of 
the M. tuberculosis population structure involved analysis of SNPs in the katG and gyrA 
genes and defined three major genetic groups (Sreevatsan et al., 1997). Later surveys have 
extended this strategy to include more than 100 sSNPs identified in 112 M. tuberculosis 
isolates (Gutacker et al., 2002). In more recent work using 159 sSNPs identified by whole-
genome comparison of sequenced strains, it was possible to classify 212 isolates into 56 
haplotypes that grouped strains into six M. tuberculosis SNP Cluster Groups (SCG) and one 
SCG that grouped all the M. bovis strains (Filliol et al., 2006). A re-evaluation of the SNP 
phylogeny was obtained by using de novo sequencing of 89 randomly distributed genes in 
108 global strains (Comas et al., 2009). This study suggested that initial classification could 
be done using a subset of discriminatory SNPs and then, if further molecular 
characterization were needed, a MIRU-VNTR typing technique could be applied to 
differentiate individual strains. However, the choice of discriminatory SNPs is not an easy 
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task. For example, SNPs comparison in 32 fully sequenced strains that caused an outbreak in 
a community in Canada, allowed the identification of two co-circulating “lineages” with the 
same MIRU-VNTR profile (Gardy et al., 2011), which would not have been evident if only 
the discriminatory SNPs used previously had been included. The study allowed tracking the 
transmission and demonstrated the power of coupling comparative genomics with social 
epidemiological studies. 
Genetic variation at the SNP level can also have profound implications in strain fitness and 
disease outcome. One such case applies to the Esx protein family that has been implicated in 
host-pathogen interactions. To survey genetic diversity in the Esx family, and its potential 
for antigenic variation, all esx genes were sequenced from 108 clinical isolates of  
M. tuberculosis belonging to different clades. The SNP distribution affecting Esx proteins 
indicated high genetic variability and a total of 109 unique SNPs, 59 of which were non-
synonymous. Some of the resultant amino acid substitutions affected known Esx epitopes 
likely to result in immune variation, thus revealing a dynamic esx gene family (Vasilyeva et 
al., 2009).  
Another important area of research focuses on variability associated with specific 
phenotypes of clinical importance, such as antibiotic resistance. In M. tuberculosis, resistance 
to antibiotics results essentially from mutations, such as SNPs, that can be acquired during 
treatment and can spread within the population. The mutations conferring antibiotic 
resistance can have a variable effect on strain fitness and bacteria can develop compensatory 
mechanisms to recover fitness capacity (Borrell & Gagneux, 2011). Isoniazid (INH) 
resistance  in M. tuberculosis is associated with mutations in the genes katG, inhA and ahpC. 
Most identified mutations map to katG, which encodes the catalase-peroxidase required to 
activate INH (Ramaswamy & Musser, 1998) and to protect M. tuberculosis from the oxidative 
free radicals in the macrophage. Thus M. tuberculosis INH resistant strains are less virulent 
(Pym et al, 2002). However, the katGS315T mutation, the most common mutation for INH 
resistance (Sandgren et al., 2009), results in reduced INH activation while maintaining KatG 
activity and virulence in mice (Pym et al., 2002) suggesting compensatory evolution as has 
been suggested in other bacteria (Maisnier-Patin & Andersson, 2004). If compensatory 
evolution occurs in MDR and XDR strains it will have deep impacts in the control of 
tuberculosis (Borrell & Gagneux, 2011), an area that must be further investigated.  
The identification of SNPs associated with resistance has also indicated the existence of 
multiple gene determinants for resistance, not all of which have been fully identified. 
Streptomycin (Sm) resistance, for example, is associated in the majority of cases with 
mutations in rpsL and rrs (Sreevatsan et al., 1997). However, 27% of Sm-resistant strains lack 
mutations in these genes. There is evidence that in some cases mutations in gidB, a gene 
coding for a 7-methylguanosine (m7G) methyltransferase specific for 16S rDNA, are 
associated with low level of Sm resistance (Donoghue, 2011). However, some susceptible 
strains also contain such mutations, thus requiring sequence analysis of more M. tuberculosis 
clinical isolates to better understand the role of gidB gene mutations in Sm resistance. 
A longstanding question in tuberculosis has been the precise mechanisms by which 
mycobacteria can acquire resistant mutations, especially during latent infections. The 
mutation rates that confer antibiotic resistance have been determined in vitro, yet the slow 
growth and different metabolic states of M. tuberculosis during infection make it difficult to 
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assess the in vivo rates.  This was achieved in a recent report, however, using whole genome 
sequencing and identification of SNPs generated during different disease states in macaque 
monkeys (Ford et al., 2011). Similar mutation rates were observed during latency and during 
active disease, and these were also consistent with in vitro rates. Based on these results and 
on the types of SNPs observed, it was suggested that M. tuberculosis can acquire mutations 
during latency and that these mutations are the result of oxidative DNA damage rather than 
errors in replication. This could be explained by increased oxidative damage during latency, 
as a result of the immune response, or by diminished DNA repair in metabolically quiescent 
bacilli (Ford et al., 2011). 
The identification of SNPs in M. tuberculosis has provided important insight regarding 
genetic variability and evolution of this pathogen. SNPs can also impact strain fitness, as is 
evident by the acquisition of antibiotic resistance markers. It remains to be seen if many of 
the identified SNPs have an effect on the biology of M. tuberculosis and the host-pathogen 
interaction. Whole genome sequencing will undoubtedly allow more extensive SNP 
identification and analysis on a genome-wide scale. As more sequence data becomes 
available, comparative genomics studies may help to identify markers that can contribute to 
our understanding of the molecular mechanisms underlying phenotypes such as drug 
resistance and persistence.  
4. Large Sequence Polymorphisms 
LSPs can include both insertions and deletions (indels) and have been identified as one of 
the main sources of genomic variability in M. tuberculosis. The effect of LSPs can vary and 
may provide insights into the biology of M. tuberculosis strains. Large deletions have been 
shown to group closely related strains and have been associated with phylogeographical 
lineages, suggesting that a deletion event is specific to a particular lineage (Tsolaki et al., 
2004). Some LSPs occur rarely in the population and could have arisen from random 
genomic events and then become associated with a particular phylogenetic lineage (Alland 
et al., 2007). In contrast, other LSPs are present in multiple strains from different lineages, as 
a result of selective pressure, and are not necessarily associated with particular groups 
(Alland et al., 2007). 
Soon after completing the genome sequence of the laboratory strain H37Rv (Cole et al., 
1998), the clinical isolate, strain CDC1551 that had caused an outbreak in the United States, 
was sequenced (Fleischmann et al., 2002). A whole genome comparative study carried out 
using these two genomic sequences identified 1,075 SNPs and 86 LSPs larger than 10 bp. The 
analysis of these LSPs using a panel of 169 clinical isolates, showed that clinical strains were 
genetically more variable than expected from a clonal bacterial population (Fleischmann et 
al., 2002).  
The continued advances in methods for high-throughput nucleic acid sequencing now allow 
more rapid generation of sequence data and thus access to information from a growing 
number of sequenced clinical M. tuberculosis genomes. Up to now, there are more than 200 
on-going sequencing projects of M. tuberculosis strains with different characteristics, such as 
strains with epidemic potential and strains characterized by multidrug resistance, as well as 
isolates obtained before and after a passage through an immunocompetent animal model, 
among others (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi). This information, 
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together with new bioinformatics algorithms will be an invaluable resource for probing 
these genomes in an effort to further understand the evolution, epidemiology, emergence of 
drug resistance and phenotypic variability associated with tuberculosis disease. 
4.1 Comparative genomics to assess variability 
With the growing number of sequenced strains becoming available, the comparison of 
complete genomes from different clinical isolates of M. tuberculosis becomes an attractive 
and powerful tool to explore genotypic similarities and differences. This approach can also 
provide important insights regarding the genotype-phenotype relationship in M. 
tuberculosis, and can therefore contribute to the development of control measures for 
tuberculosis. In this respect, we carried out whole genome comparisons of six fully 
sequenced M. tuberculosis strains, four clinical isolates and two laboratory strains which 
showed high synteny, as expected, and no large rearrangements (Cubillos-Ruiz et al., 2008), 
except for a large inversion seen in the KZN strain that could be due to sequencing errors 
and incomplete data (Figure 2). Most of the 1,428 LSPs identified were indels involving 120 
genes that affected primarily 1) mobile genetic elements such as insertion sequences and 
prophages, 2) non-coding regions, and 3) the PE/PPE family of genes. The LSPs identified in 
this work differed among strains, were distributed along the entire genome and were used 
to identify strain-specific insertions and deletions. When fitted to an exponential decay 
function these data indicated a tendency towards accumulation of more deletions than 
insertions, consistent with the notion of genome decay in M. tuberculosis (Cubillos-Ruiz et 
al., 2008). One other remarkable finding was that laboratory strains contained less strain 
specific polymorphisms than the clinical isolates, suggesting that the selective pressure 
imposed by the human immune system could be driving variability. The existence of strain-
specific polymorphisms also opened the possibility that specific indels could be associated 
with particular lineages and thus could also be used as markers for strain typing and 
surveillance.  
Taking into account the growing evidence of the phylogeographical origin of M. tuberculosis 
(Gagneux et al., 2006, Wirth et al., 2008), we speculated that the strain-specific 
polymorphisms could be common to strains of a particular lineage rather than being an 
exclusive property of one particular isolate. To test this hypothesis, we evaluated strain-
specific indels and previously identified SNPs associated with strains of the Haarlem lineage 
using a large panel of well-characterized M. tuberculosis strains (Olano et al, 2008, Cubillos-
Ruiz et al., 2008). Six large deletions, two specific IS6110 insertions and two SNPs were 
significantly associated with the Haarlem family and thus proposed as genomic signatures 
of this lineage (Cubillos-Ruiz et al., 2010). These results were completely congruent with 
spoligotyping and with RFLP data, as well as with the new assignation of a URAL family 
instead of the Haarlem 4 sublineage (Abadia et al., 2010). One particularly interesting result 
was the identification of deletions that affected previously proposed drug targets. These 
include the gene Rv1354c, which encodes a diguanylate cyclase (DGC) enzyme involved in 
regulating the levels of c-di-GMP, a bacterial second messenger implicated in survival and 
adaptation to different environmental conditions (Gupta et al., 2010), and gene Rv2275 that 
codes for a cytochrome P450, Cyp121 (McLean & Munro, 2008). Both of these genes were 
deleted in the Haarlem strains analyzed, indicating that they would not be adequate targets 
for antimicrobials. Although this particular study was limited to Haarlem strains, it raises 
the possibility that other lineage-specific genomic differences might impact treatment and 
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control. More studies will be needed to address this issue and to verify the presence of 
specific gene targets.  
 
Fig. 2. Whole genome alignment generated with the MAUVE software, showing synteny 
and, in the case of strain KZN, the presence of a genomic inversion. 
5. Insertions 
The presence of insertion elements in different bacteria has been well appreciated for some 
time, especially because of the impact they can have on the host genome (Siguier et al., 2006). 
Insertion elements can not only re-shape the genome but can also cause mutations and alter 
gene expression. In the case of pathogens such as M. tuberculosis the presence of insertion 
elements can generate genotypic variation and mediate changes that can affect gene 
function. This variability can therefore alter properties such as strain fitness and 
transmissibility and even play a role in the evolution of M. tuberculosis.  
The insertion elements present in the M. tuberculosis genome were described in detail upon 
completion of the M. tuberculosis H37Rv whole genome sequence (Gordon et al., 1999). M. 
tuberculosis harbors four main insertion elements, IS6110, IS1081, IS1547 and the IS-like 
element, all of them present in multiple copies. The best studied of these is the 1.36Kb 
IS6110, originally described by Thierry et al. in 1990 (Thierry et al., 1990), which belongs to 
the group of IS3 elements and is characterized by having two partially overlapping open 
reading frames that allow production of a transposase by translational frameshifting 
(McEvoy et al., 2007). It also has 28 bp imperfect terminal inverted repeats and generates 3- 
to 4 bp direct repeats upon insertion (McAdam et al., 1990, Thierry et al., 1990, Mendiola et 
al., 1992). The IS6110 element is present exclusively in strains of the MTBC that can harbor 
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from zero to 25 copies per genome (Brosch et al., 2000). For this reason and due to its high 
degree of copy number and insertion site variation, IS6110- RFLP has been widely used for 
epidemiological purposes and is considered the “gold standard” to study the transmission 
dynamics of M. tuberculosis (van Embden et al., 1993, Small et al., 1994, Safi et al., 1997). The 
discriminatory power of the IS6110-RFLP method depends on there being sufficient 
variation and copy number to differentiate between unlinked isolates while allowing 
identification of specimens that are related (Wall et al., 1999). Thus IS6110-RFLP is used to 
distinguish between epidemiological events but its use as marker for strain evolution is still 
under debate (McEvoy et al., 2007).  
The consequence of IS6110 transposition can differ depending on the position of integration, 
with phenotypic outcomes ranging from lethality to its bacterial host due to gene 
inactivation to possible benefits.  There are four mutational events that can be generated by 
IS6110 transposition: 1) Integration in intragenic regions; 2) Alteration of IS6110 flanking 
regions; 3) Recombination/gene deletion; 4) Alteration of IS6110 promoter activity (McEvoy 
et al., 2007). Intragenic insertions interrupt open reading frames and can inactivate genes; 
this is the most frequently described event in certain clinical isolates. For these interruptions 
to be observed they must occur in genes that are dispensable for survival of the bacterium or 
are redundant in function. These insertion events can also alter immune recognition or 
virulence properties, as has been suggested for insertions in members of the PPE gene 
family or in the phospholipase C gene region (McEvoy et al., 2009a, Vera-Cabrera et al., 
2001). It has also been observed that the regions flanking an IS6110 insertion contain 
additional mutations, suggesting that this element can have a disruptive effect on the DNA 
region of insertion that results in mutations (Warren et al., 2000).  
Insertion elements can mediate deletions, as has also been shown for M. tuberculosis, where 
gene deletion can occur by homologous recombination between two flanking copies of 
IS6110. For example, deletion of the plcA gene in clinical M. tuberculosis strains displays a 
decrease capacity to cause pulmonary cavitation, clearly showing the phenotypic effects of 
transposition in a clinical setting (Kato-Maeda et al., 2001a). Not all the insertions described 
in clinical isolates have deleterious or silent effects on the mycobacterial cell; some studies 
have reported that IS6110 can up-regulate expression of downstream genes from an 
outward-directed promoter at its 3’ end, conferring selective advantages. In particular, an 
insertion found within the phoP promoter region in an MDR M.bovis strain, which had 
produced outbreaks in the United States and Spain (Rivero et al., 2001), was shown to 
increase phoP expression 10-fold in M. smegmatis and was proposed to be responsible for the 
high transmissibility levels of the original M. bovis isolate (Soto et al., 2004).  
Given the high variability of IS6110 elements in the genomes of MTBC strains and the 
possible consequences of insertion on strain phenotype, there has been an interest in 
identifying the precise insertion locations in M. tuberculosis clinical isolates. Different 
methodologies developed, based on PCR, sequencing and cloning, have suggested that the 
IS6110 element inserts preferentially into non-coding regions (Otal et al., 2008, Warren et al., 
2000, Thorne et al., 2011, Kim et al., 2010, McEvoy et al., 2009b, Wall et al., 1999). This can be 
explained by the fact that insertions in functional genes essential for strain growth, 
maintenance and pathogen integrity would be harmful to the cell and thus, not maintained 
in the population. Preferential insertion loci or hotspots have also been identified, some of 
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which include the phospholipase C region (Vera-Cabrera et al., 2001), members of the PPE 
gene family (McEvoy et al., 2009a), the dnaA - dnaN intergenic region (Turcios et al., 2009), 
the RD724 gene (Kim et al., 2010) and insertion into the IS1547 element (Fang et al., 1999). 
PPE genes are considered to be important antigens during the host-pathogen interaction and 
have been proposed to play a role in evasion of the immune response (Sampson, 2011). Thus 
variability in the PPE genes generated through IS6110 transposition could help to evade the 
immune system during infection and confer advantage to strains. In contrast to these 
hotspot regions, some loci where integration is rare or not observed have also been 
identified and these represent sites where in vivo transposition events can be harmful to 
strain fitness and growth (Yesilkaya et al., 2005).  
We recently developed a novel high-throughput method using next-generation sequencing 
to identify the flanking regions of the IS6110 insertion element in over 500 M. tuberculosis 
isolates mainly from Latin-America and Europe. In this study we identified previously 
reported hotspot regions of insertion as well as novel sites (Table 1) (Reyes et al., submitted). 
 
Locus Gene ID Description # strains
# independent 
sites 
Hotspots 
MT3426:MT342
7 (RvD5) 
MT3426:
moaA-3 
 195 1 A 
Rv0403c mmpS1 
Probable conserved 
membrane protein 
225 6 A*, H 
Rv0835:Rv0836c 
lpqQ: 
Rv0836c 
 227 5 A 
Rv1754c - 
Conserved 
hypothetical protein 
394 4 A* 
Rv2336 - Hypothetical protein 188 2 A* 
Rv2814c-
Rv2815c 
- IS6110, transposase 485 2 A* 
Rv3113 - Possible phosphatase 218 2 A 
Table 1. Hotspot insertion sites in M. tuberculosis identified by high-throughput sequencing 
(Reyes et al., submitted). Hotspots (H) or Ancestral (A) insertions for a given lineage; A* 
indicates an ancestral insertion in a locus in that more than one lineage. 
The copy number of IS6110 elements in the genomes of circulating M. tuberculosis strains can 
be highly variable and is ultimately limited by the deleterious effects of IS6110 transposition 
(McEvoy et al., 2007). Although most M. tuberculosis isolates have multiple copies of the 
IS6110 element, the presence of a copy in the DR region of the MTBC strains suggests that 
this could be an ancestral insertion site. It has also been observed that some successful M. 
tuberculosis strains tend to have a high copy number of the IS6110 element and that this 
might correlate with phenotypic properties (Alonso et al., 2011). In a recent report, a Beijing 
family strain considered to have a high transmissibility rate was found to have 19 copies of 
the IS6110 element, four of which were shown to up-regulate downstream gene expression. 
One of these was in the gene Rv2179c, which is normally expressed inside macrophages, 
suggesting that this gene could influence the infectious process and that the strain’s high 
degree of transmissibility could be due to the up-regulation caused by the IS6110 insertion 
(Alonso et al., 2011). However, some clinical strains and MTBC members with a low number 
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of copies of the IS6110 are also epidemiologically successful. In general, though, there is still 
insufficient information regarding the factors that influence the frequency of transposition, 
such as the genomic context of the insertion element within a particular strain background. 
The variation in the number of IS6110 elements among M. tuberculosis isolates also raises the 
possibility that copy number is the result of the evolution of particular lineages as strains 
cope with IS6110 transposition and its resulting genetic variability, and in some cases even 
selecting for phenotypically favorable events, while keeping genome integrity and avoiding 
deleterious effects. 
6. Implication of variability on disease control 
From the pool of individuals that come in contact with and are infected with M. tuberculosis, 
only about 10% will develop disease. The manifestation of the disease in these individuals, 
however, can vary greatly from a self-limited infection in the lungs to extra-pulmonary and 
disseminated cases (Nicol & Wilkinson, 2008). The outcome of infection must therefore be 
influenced both by host factors that may predispose to infection, and to genetic variation in the 
tubercle bacillus itself. Several host factors have been associated with risk for disease, such as 
malnutrition, vitamin D deficiency, NRAMP1 polymorphisms, diabetes and co-infection with 
HIV (Malik & Godfrey-Faussett, 2005). A recent study analysing the impact of pathogen 
variability in recombinant congenic mice indicated that host control of the infection varied 
depending on the infecting strain and the stage of infection. The dynamic response to disease 
suggests that in addition to host genetic determinants, the pathogen background also 
influences the outcome of infection (Di Pietrantonio et al., 2010).  Studies with both laboratory 
and clinical strains have also suggested a correlation between strain genotype and the 
infectious process. This correlation, however, has been difficult to resolve in great part due to 
the difficulty associated with working with this slow-growing pathogen and to problems 
associated with extrapolation from animal models (Nicol & Wilkinson, 2008). The integration 
of genomics and epidemiological data has been able to link some cases of genetic variability 
with strain phenotypic characteristics. By analysing deletions in clinical isolates it was 
suggested, for example, that strains causing cavitary disease had fewer deletions, indicating 
that the accumulation of mutations affected pathogenesis (Kato-Maeda et al., 2001b). Mutations 
that altered the PE_PGRS33 protein, which may be involved in cell-cell interactions and 
antigenic variation, have also been connected with clustering and pathogenesis and thus with 
clinical and epidemiological characteristics of M. tuberculosis isolates (Talarico et al., 2007). 
Similarly, an analysis of the genetic variation at the plcD locus indicated that variability in this 
region was possibly associated with pathogenesis and disease manifestation (Yang et al., 2005). 
Studies involving strains that cause pulmonary and extra-pulmonary infections have also 
indicated that extra-respiratory strains were more efficient at infecting macrophages and could 
also have higher infectivity in vivo (Garcia de Viedma et al., 2005).  
The growing consensus that the main MTBC lineages are associated with geographic origin 
suggests co-evolution of lineages with their hosts and thus adaptation that must involve 
events of strain variation. More recent evidence of the restricted geographical niche of 
certain lineages came from an Ibero-America MDR M. tuberculosis survey showing that 
circulation of Latin American MDR strains was restricted to particular areas and also that 
transnational transmission was scarce (Ritacco et al., 2011). The Beijing lineage, one of the 
most extensively studied families, has been responsible for several epidemic outbreaks and 
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in some cases has been associated with multidrug resistance (Hanekom et al., 2011). Its 
capacity to spread within a population is evident from epidemiological studies and 
emphasizes the possibility that certain strain properties could contribute to this lineage’s 
expansion in the population (Nicol & Wilkinson, 2008). The increased virulence of these 
isolates was associated with the production of a phenolic glycolipid (PGL) that affects the 
host immune response, and which is absent in many other M. tuberculosis families (Ordway 
et al., 2007, Hanekom et al., 2011). More recent work suggests that although PGL can 
contribute to M. tuberculosis virulence, it probably requires additional bacterial factors 
(Sinsimer et al., 2008). Other examples stem from studies of strains that have caused 
outbreaks, such as strains CDC1551 and HN878, the latter also a member of the Beijing 
family. In these and other studied cases, it appears that some of the effects observed have to 
do with the capacity of these strains to induce variable inflammatory responses (Coscolla & 
Gagneux, 2010). Despite these studies, many of the clinical outcomes associated with strain 
variability still need to be further examined, particularly in other M. tuberculosis lineages 
before precise genotypic variability can be associated with phenotypic differences.  
The emergence and spread of drug-resistant strains is particularly disturbing and provides 
additional examples where strain variability can have a profound effect on disease outcome. 
One particularly alarming case was the epidemic caused by an XDR strain in the KwaZulu-
Natal region of South Africa that resulted in high mortality, causing the death of 52 of the 53 
patients co-infected with HIV in the course of 16 days (Gandhi et al., 2006). To understand 
more about the dynamics of appearance and dispersion of this highly virulent KZN strain, 
whole genome sequence analysis was carried out for XDR, MDR and drug sensitive KZN 
strains. The results indicated that the outbreak was most probably due to clonal expansion 
of a single strain and that a particular strain genetic background did not necessarily 
contribute to acquisition of antibiotic resistance (Ioerger et al., 2009). Further work will be 
needed to better understand this strain’s virulence and transmissibility in the community.   
Part of the success of M. tuberculosis as a human pathogen is due to its capacity to be 
efficiently transmitted between hosts and to persist for long periods of time despite the 
host’s immune response. A recent study involving whole genome sequencing of 21 strains 
from the six main M. tuberculosis lineages indicated that human T cell epitopes had very 
little sequence variation and were highly conserved relative to the rest of the genome. It was 
suggested that these antigens, contrary to expectations, might be under purifying selection 
and be benefitting from host immune recognition (Comas et al., 2010).  This differs from the 
classical view of immune evasion due to the selective pressure imposed by the immune 
response and may indicate that new approaches should be considered for vaccine 
development and control of M. tuberculosis.  
The genetic variability evident in strains of the MTBC bears relevance to control of 
tuberculosis since treatment must work against all circulating strains. Rapid and accessible 
diagnostics for both M. tuberculosis and drug resistant isolates are still required, as is the 
availability of a vaccine that can be universally effective, given the variable efficacy of the 
currently used BCG vaccine. There are now more that 10 vaccines under phase I trial and 
the hope is that in the near future at least one of these will prove to be safe and protective by 
containing M. tuberculosis and preventing reactivation. However, future strategies will need 
to address the need to prevent or eradicate latent infections, especially in view of additional 
factors affecting disease and the host immune response, such as co-infection with HIV 
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(Kaufmann, 2010). New and alternative drugs are also required to shorten the current 
duration of chemotherapy, to act against persistent bacilli and to counteract the spread of 
drug-resistant strains that frustrate global eradication programs. Due to renewed efforts in 
recent years, several novel drugs have been identified and are under clinical evaluation or 
being developed, many of which involve novel targets and mechanisms (Coxon & Dover, 
2011). The discovery of novel drugs has involved different approaches that include the use 
of genomics to identify targets, whole-cell screening and re-engineering of known chemical 
molecules (Koul et al., 2011). Given the observed strain variability it is nonetheless possible 
that some of these drugs might vary in efficiency in different strain backgrounds, as was 
made evident for DGC and Cyp121 in the Haarlem lineage (Cubillos-Ruiz et al., 2010). Thus 
the heterogeneity among different strains and lineages, as well as of the host-pathogen 
interaction, must be taken into account when developing novel diagnostics and therapeutic 
strategies. Extensive analysis of circulating M. tuberculosis populations will be required to 
address the efficacy of treatment and vaccination in different genetic backgrounds. The 
advent of novel massive sequencing techniques to generate genomic data for multiple 
strains will undoubtedly allow examination of whole genomes and make such analyses 
more feasible (Lin & Ottenhoff, 2008). 
7. Concluding remarks  
Over the last decades there has been a substantial increase in our understanding of the 
molecular bases of M. tuberculosis biology and its interaction with the host. However, the 
clinical and epidemiology consequences of M. tuberculosis infection are still poorly 
understood. Despite the restricted variability and clonality of the MTBC population, various 
studies make evident that circulating strains vary in terms of their genomic makeup and 
differ with respect to virulence and immunogenicity properties. The differences observed in 
the interactions between pathogen and host and in disease manifestation indicate that 
variation must play a role in disease and in clinical outcome, even though the extent of the 
impact of this strain diversity is still unclear (Coscolla & Gagneux, 2010). Thus, the precise 
role of bacterial factors and the importance of strain diversity in pathogenicity and 
tuberculosis disease remain elusive, partly due to the complex interplay between host and 
pathogen that is compounded by additional environmental factors. The strain-to-strain 
variation also has important consequences for the development of efficient control 
strategies. The development of new diagnostics tools, drugs and vaccines must somehow 
incorporate analysis of the differences that characterize host responses and strains, 
highlighting the importance of continued studies regarding the genetic makeup of 
circulating strains.  The use of modern genetic and molecular tools, including the 
availability of massive sequencing techniques, can contribute significantly to our 
understanding of M. tuberculosis variability and its possible association with biological 
properties. Only by realizing the need to incorporate this added level of complexity to the 
study of tuberculosis, will we be able to tackle the intricacies of this disease and achieve an 
adequate level of control on a global scale. 
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